Sort
15,842 grants matching “pancreatic cancer”
Molecular Imaging Guidance for Potentiating Chemoimmunotherapy in Pancreatic Cancer using Photodynamic Priming
$640,089Girgis Obaid · University Of Texas Dallas · R01 · FY2024 · EB
Targeted EGFR for basal subtype pancreatic cancer
$639,879Jen Jen Yeh · Univ Of North Carolina Chapel Hill · R01 · FY2024 · CA
Targeted EGFR for basal subtype pancreatic cancer
$639,879Jen Jen Yeh · Univ Of North Carolina Chapel Hill · R01 · FY2025 · CA
CCR FACS Core Laboratory
$639,679Karen Wolcott · Division Of Basic Sciences - Nci · ZIC · FY2012 · CA
Neural Mechanisms of Nausea, Vomiting, and Energy Dysregulation
$639,550Bart C De Jonghe · University Of Pennsylvania · R01 · FY2023 · DK
Neural Mechanisms of Nausea, Vomiting, and Energy Dysregulation
$639,550Bart C De Jonghe · University Of Pennsylvania · R01 · FY2025 · DK
Project 3: Regulatory RNAs as Cancer Drivers and Dependencies
$639,360David L Spector · Cold Spring Harbor Laboratory · P01 · FY2023 · CA
Project 3: Regulatory RNAs as Cancer Drivers and Dependencies
$639,360David L Spector · Cold Spring Harbor Laboratory · P01 · FY2025 · CA
Project 1: Clinical and immune impact of radiation and dual checkpoint blockade in patients
$639,331Robert H Vonderheide · University Of Pennsylvania · P01 · FY2022 · CA
P-selectin-Mediated Targeting of PI3K Nanomedicines to the Tumor Microenvironment
$639,270Daniel Alan Heller · Sloan-Kettering Inst Can Research · R01 · FY2020 · CA
P-selectin-Mediated Targeting of PI3K Nanomedicines to the Tumor Microenvironment
$639,270Daniel Alan Heller · Sloan-Kettering Inst Can Research · R01 · FY2021 · CA
ECM geometrical and mechanical properties modulate RTK signaling
$639,231Jay T. Groves · University Of California Berkeley · U01 · FY2016 · CA
ECM geometrical and mechanical properties modulate RTK signaling
$639,231Jay T. Groves · University Of California Berkeley · U01 · FY2018 · CA
Targeting Intrinsic and Extrinsic Barriers to Treat Metastatic Pancreatic Cancer
$639,098Scott Andrew Gerber · University Of Rochester · R01 · FY2025 · CA
Discovery of Pancreatic Signatures in Type 2 Diabetes Mellitus
$639,010Alvin Carter Powers · Vanderbilt University · R24 · FY2015 · DK
Leveraging CD26high Meso-CAR T cells in patients with advanced pancreatic cancer
$638,929Gregory B. Lesinski · Emory University · R01 · FY2025 · CA
Animal Core Facility
$638,854John Curlee Wilkinson · North Dakota State University · P20 · FY2022 · GM
Use of Circulating MicroRNAs for Early Detection and Risk Assessment for Pancreatic Cancer
$638,665Xiao-Ou Shu · Vanderbilt University Medical Center · R01 · FY2020 · CA
Project 2: : Systematic discovery of cell-extrinsic mechanisms of cancer drug resistance
$638,188Alex K Shalek · Massachusetts Institute Of Technology · U54 · FY2018 · CA
Mesothelin-targeted immunotoxins in Pancreatic Cancer
$638,124Christine Alewine · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Utilizing nucleic acid scavengers to elucidate how DNA/RNA-containing DAMPs promote pancreatic cancer metastasis and to mitigate such processes
$638,056Bruce Alan Sullenger · Duke University · R01 · FY2025 · CA
Magnetic resonance Imaging as a Non-Invasive Method for Assessment of Pancreatic fibrosis (MINIMAP): a pilot study
$638,049Evan L Fogel · Indiana University Indianapolis · R01 · FY2019 · DK
Development of a theragnostic radiopharmaceutical for pancreatic cancer
$638,027Katherine W Ferrara · Stanford University · R01 · FY2025 · CA
Endoscopic Fine-Needle Light Scattering Spectroscopy for Pancreatic Cyst Diagnosis and Evaluation of Malignant Potential
$637,971Lev T. Perelman · Beth Israel Deaconess Medical Center · R01 · FY2024 · EB
Roles of NADPH Oxidase 5 and Dual Oxidase 2 in Cancer
$637,940James Doroshow · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA